Edition:
India

People: Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

32.03USD
1:30am IST
Change (% chg)

$0.29 (+0.91%)
Prev Close
$31.74
Open
$31.49
Day's High
$32.60
Day's Low
$31.49
Volume
115,333
Avg. Vol
149,667
52-wk High
$41.59
52-wk Low
$18.00

Goldberg, Mark 

Dr. Mark Goldberg is Independent Director of the Company. since December 2017. Dr. Goldberg holds an A.B. from Harvard College and an M.D. from Harvard Medical School. Our board of directors believes that Dr. Goldberg’s extensive experience in oncology, rare disease and gene therapy development and the biotechnology industry qualifies him to serve on our board of directors. Dr. Goldberg holds an A.B. from Harvard College and an M.D. from Harvard Medical School. Our board of directors believes that Dr. Goldberg’s extensive experience in oncology, rare disease and gene therapy development and the biotechnology industry qualifies him to serve on our board of directors.

Basic Compensation

Total Annual Compensation, USD 40,740
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 768,220
Fiscal Year Total, USD 808,960

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --